Merova Healthcare Holding
04Merova CMO

Manufacturing selected healthcare products in Abu Dhabi.

A cost-plus contract manufacturing engine built around portfolio companies and proprietary healthcare products.

4.1Operating Model

Cost-plus, not commodity.

Merova CMO operates as a captive-anchor facility: dedicated lines for portfolio companies under cost-plus economics. The result is durable margin transfer to the platform and supply chain control that cannot be replicated by third-party CMOs.

4.2Economics
Model
Cost-plus contract manufacturing
Customer
Merova portfolio companies (primary)
Pricing
Cost-plus rent · cost-plus utilized labor · cost-plus margin
Location
Abu Dhabi — Made in Emirates
Capacity Phasing
Modular line build-out aligned to portfolio approvals
Peak Revenue
Scaled with portfolio commercialization [Target]
4.3Strategic Advantages
01

In-country value

Made-in-Emirates qualification unlocks GCC procurement preference and regulatory familiarity.

02

Supply resilience

Reduces reliance on US/EU shipping lanes — critical for diagnostics and consumables.

03

Cost compression

Labor, energy and tax structure deliver durable margin uplift for portfolio companies.

04

Capacity dedicated

Lines configured for proprietary products — quality and IP control retained inside the platform.

4.4Candidates for In-Country Manufacturing

  • Drug-Device Combination

    BioQ Pharma

    Proprietary invenious™ infusion platform. Four approved products with 44 global marketing authorizations and 50+ US patents across pain, anesthesia and oncology.

  • AI-Enabled Diagnostics

    Periwinkle Technologies

    Smart Scope® CX detects cervical cancer in under five minutes, offline-capable. Pre-IPO. Pipeline includes oral and breast cancer screening.

  • Therapeutic Devices

    Revian

    FDA-cleared LED hair regrowth platform. 65+ patents and ~75% gross margins. Channels across physicians, affiliates and DTC.

  • Aesthetic Laser Technology

    Bellamia

    Botticelli™ Athena and Primavera — multi-wavelength skin rejuvenation platforms. Five awarded patents. Razor / razor-blade revenue model.

  • Neurotechnology · Devices

    Vermillion Health

    Non-invasive EEG-based chronic pain treatment. Hardware plus SaaS subscription, addressing a large global market without drugs.

Investor inquiriesPartner with CMO →